1 / 19

U.s. Vaccine Market Analysis (2020-2027)

Read here the market research report on the u201cU.S. Vaccine Market" published by CMI Team

kunalbhuta
Télécharger la présentation

U.s. Vaccine Market Analysis (2020-2027)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. U.S. VACCINE MARKET ANALYSIS(2020-2027) • U.S. Vaccine Market, By Product Type (Human Vaccine (Pediatric Vaccines, Adult & Adolescent Vaccines, Other Human Vaccines), Animal Vaccine (Livestock Vaccines, Companion Animal Vaccines, Other Animal Vaccines)), By End User (Hospitals, Clinics Vaccination, Centers) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

  3. A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. Inactivated, attenuated, toxoid, subunit, conjugate, heterotypic, experimental, and valence are the types of vaccines. • U.S. vaccines market is estimated to account for US$ 19,355.2 Mn in terms of value in 2020 and is estimated to account for US$ 27,947.4 Mn by the end of 2027.

  4. U.S. Vaccines Market: Drivers • Emergence of Covid-19 is expected to propel growth of the U.S. vaccines market over the forecast period. For instance, in the U.S. from January 20, 2020 to 6:01 pm CEST, 6 July 2020, there have been 2,833,552 confirmed cases of COVID-19 with 129,408 deaths, as reported to the World Health Organization.

  5. Moreover, R&D initiatives for new vaccines is also expected to aid in growth of the market. For instance, in March 2020, IQVIA and Quest Diagnostics, through its joint venture Q2 Solutions, collaborated with the University of Texas Medical Branch to develop a novel assay for COVID-19 tests for rapid development of a Coronavirus vaccine. • Human vaccine held dominant position in the U.S. vaccines market in 2019, accounting for 81.7% share in terms of value, followed by animal vaccine respectively.

  6. Figure 1. U.S. Vaccines Market Share (%), by Value, by Vaccine Type, 2019

  7. U.S. Vaccines Market: Restraints • High cost of refrigeration of vaccines is expected to hinder growth of the market. For vaccines, refrigeration is mandatory to prevent alteration of their chemical structure mainly due to contact with water and humidity resulting in ineffective medications. Maintaining this cold chain from production until they are used in treatment is a costly process accounting for about 80% of the price of vaccinations. • Moreover, short functional shelf life of certain vaccines is also expected to limit the market growth.

  8. U.S. Vaccines Market: Opportunities  • Building registry platform and database regarding COVID-19 is expected to offer lucrative growth opportunities for players in the U.S. vaccines market. For instance, in April 2020, Clara Health, a software startup, collaborated with Lyft, Inc., a ridesharing company, and VSC, a public relations agency, to build the registry platform and database to connect COVID-positive and -negative individuals with clinical trials for diagnostics, treatment and vaccine discovery.

  9. Moreover, initiatives to promote R&D in poultry is also expected to aid in growth of the market.  For instance, in May 2020, The U.S. Poultry Foundation awarded a US$ 7,000 grant to the University of North Georgia to recruit students into the poultry science program. • U.S. vaccines market was valued at US$ 18,367.0 Mn in 2019 and is forecast to reach a value of US$ 27,947.4 Mn by 2027 at a CAGR of 5.4% between 2020 and 2027.

  10. Figure 2. U.S. Vaccines Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

  11. Market Trends/Key Takeaways • Major players in the market are focused on adopting partnership and collaboration strategies to expand their product portfolio. For instance, in April 2020, Sanofi Pasteur collaborated with GSK to develop an adjuvanted vaccine for COVID-19. • Stringent regulations that promote vaccination are boosting the market growth. For instance, in January 2020,            the Government of New Jersey, U.S., mandated college students to be vaccinated against bacterial meningitis as a condition for attending an institution.

  12. Regulations • The Center for Biologics Evaluation and Research (CBER) is the central regulatory agency responsible for ensuring purity, safety and efficacy of vaccines in the U.S.

  13. U.S. Vaccines Market: Competitive Landscape • Major players operating in the U.S. vaccines market include, Sanofi Pasteur, GlaxoSmithKline Plc, Merck & Company Incorporated, Pfizer Incorporated, AstraZeneca plc, and Boehringer Ingelheim.

  14. U.S. Vaccines Market: Key Developments • Major players in the market are focused on approval and launch of new vaccines to expand their product portfolio. For instance, in January 2020, Boehringer Ingelheim's U.S. Animal Health Business launched a vaccine, VAXXITEK HVT+IBD+ND that offers protection against Marek's Disease, Infectious Bursal Disease (classic and variant types) and Newcastle Disease. • Similarly, in December 2019,  NewLink Genetics Corporation received the U.S. FDA approval for ERVEBO or Zaire Ebola virus vaccine V920.

  15. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference: https://www.coherentmarketinsights.com/market-insight/us-vaccine-market-4011

  16. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  17. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  18. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related